1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
62D3642302C0CB53D65257928006BF393
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-online-patient-support-using-brand-websites-for-support?opendocument
18
19opendocument
203.90.12.112
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Marketing Management Patient Advocacy

Online Patient Support Excellence: Using Brand Website Services for Ongoing Support

ID: 5164


Features:

27 Info Graphics

10 Data Graphics

34 Metrics


Pages/Slides: 44


Published: Pre-2013


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Online Patient Support Excellence: Using Brand Website Services for Ongoing Support"

STUDY OVERVIEW

Patients with chronic conditions often need additional support beyond a prescription. The accessibility of the Internet has provided biopharmaceutical companies with an opportunity to create ongoing patient support tools on their brand websites. Web-based patient-service tools on brand sites provide ongoing support by offering a broad range of patient resources, such as calendars, reminders and expert caregiver info.

Best Practices, LLC conducted this research study to help biopharmaceutical companies incorporate ongoing support activities for patients via brand websites. Additionally, the study also illustrates some of the online tools used to support patients who use injectables, and additional insights from various brand websites and what online tools they use to engage patients (SEO, multilingual options, patient profiles and access and reimbursement aids). Brand leaders can use this study to compare their online patient support tools with the tools other brand websites are using.

KEY TOPICS

  • Online Patient Support Area: Ongoing Patient Support Resources
  • Patients Tools for Injectables
  • Achieving Online Support Leadership: Additional Website Analysis

SAMPLE KEY METRICS
  • Brand websites including treatment calendars or reminders
  • Brand websites including ongoing communications such as newsletters or updates
  • Brand websites providing personalized patient support panel
  • Brand websites offering support or information for patient caregivers
  • Brand websites providing ongoing support tools by the online support services
  • Brand websites include services for non-English speaking patients

SAMPLE KEY FINDINGS
  • Half of the Brand Websites provide diet and exercise advice or encouragement to patients: A healthy diet and exercise not only improve quality of life generally but also produce long-term salutary benefits for the health of patients suffering from chronic musculoskeletal ailments. Fifty percent of the benchmarked website offer diet, nutrition, and exercise patient support information.
  • Only few brand website offer support or information for patient caregivers: Only thirty percent of the brand websites offer support or information for patient caregivers. Caregivers can be crucial to the successful treatment of patients with chronic conditions like osteoporosis and rheumatoid arthritis.

METHODOLOGY

The benchmark framework probed 10 chronic care product websites to glean online approaches and tools for ongoing patient support. Additionally, online tools and approaches were reviewed for supporting patients who require injection treatments. Benchmark products examined include: Boniva, Cimzia, Enbrel, Forteo, Fosamax, Humira, Reclast, Remicade, Rituxan, and Simponi.

Industries Profiled:
Health Care; Pharmaceutical; Diagnostic; Biotech; Chemical; Medical Device


Companies Profiled:
Abbott; Amgen; Centocor Ortho Biotech Inc.; Eli Lilly; Genentech; Johnson & Johnson; Merck; Novartis; Roche; UCB Pharma


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.